ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing July 7, 2022, 4:00 PM ET:

Long-term morbidity and mortality in children after in utero exposure to maternal cancer (Original Report)
Iben Greiber, et al.
Request article

We Need to Talk About War Metaphors in Oncology (Editorial)
Robert McEachern, et al.
Request article

Multi-dimensional molecular profiling of metastatic triple-negative breast cancer and immune checkpoint inhibitor benefit (Original Report)
Sara Tolaney, et al.
Request article

Matched Molecular Profiling of Cell Free DNA and Tumor Tissue in Patients with Advanced Clear Cell Renal Cell Carcinoma (Original Report)
Martin Voss, et al.
Request article

Publishing July 5, 2022, 4:00 PM ET:

Relevance of Bone Marrow Biopsies for Response Assessment in U.S. National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials (Original Report)
Sarah C. Rutherford, et al.
Request article

Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood Renal Tumors (Editorial)
Michael Vincent Ortiz, et al.
Request article

Published July 1, 2022, 4:00 PM ET:

The Potential of Cancer Care Settings to Address Food Insecurity (Editorial)
Theresa Hastert, et al.
Request article

Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415 (Original Report)
Rahul Khairnar, et al.
Request article

Published June 30, 2022, 4:00 PM ET:

Modern myeloma therapy = sustained MRD negative = (functional) cure! (Editorial)
Carl Ola Landgren. et al.
Request article

Oxaliplatin (3 months versus 6 months) with 6 months of fluoropyrimidine as adjuvant therapy in patients with stage II/III colon cancer: KCSG CO09-07 (Original Report)
Young Suk Park, et al.
Request article

Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors (Original Report)
Dorien Laenens, et al.
Request article

Response and Survival Estimates of Patients With Plasma Cell Myeloma in a Resource-Constrained Setting Using Protocols From High-Income Countries: A Single-Center Experience From Sri Lanka (Original Report)
Saman Hewamana, et al.
Request article

Clinical Characteristics and Outcomes of Acute Lymphoblastic Leukemia in Adolescents and Young Adults in Malawi (Original Report)
Matthew S. Painschab, et al.
Request article

Tumor mutational burden is a potential predictive biomarker for response to immune checkpoint inhibitors in patients with advanced biliary tract cancer (Original Report)
Amit Mahipal, et al.
Request article

PARP inhibitor insensitivity to BRCA1/2 monoallelic mutations in MSI-High cancers (Original Report)
Emmanuel S. Antonarakis, et al.
Request article

Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA (ctDNA) and Correlation with Tissue Sequencing: A single Institution’s Experience (Original Report)
Lorenzo Gerratana, et al.
Request article

Published June 29, 2022, 4:00 PM ET:

Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor Positive, HER2 Negative Breast Cancer (Editorial)
Erin Frances Cobain, et al.
Request article

Published June 28, 2022, 4:00 PM ET:

Atezolizumab With Neoadjuvant Anti-HER2 Therapy and Chemotherapy in HER2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial (Original Report)
Jens Bodo Huober, et al.
Request article

Treatment Outcomes, Roles of Transplantation or Rituximab Maintenance in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts (Original Report)
Peter Martin, et al.
Request article

A Comparison of Logistic Regression Against Machine Learning Algorithms for Gastric Cancer Risk Prediction Within Real-World Clinical Data Streams (Original Report)
Robert Huang, et al.
Request article

Published June 27, 2022, 4:00 PM ET:

Antibody response to COVID-19 mRNA vaccine in lung cancer patients after primary immunization and booster: Reactivity to SARS-CoV-2 WT virus and Omicron variant (Original Report)
Rafi Ahmed, et al.
Request article

Phase III randomized trial of maintenance taxanes versus surveillance in women with advanced ovarian/tubal/peritoneal cancer: Gynecologic Oncology Group 0212:  NRG Oncology Study (Original Report)
Larry Copeland, et al.
Request article

Longitudinal COVID-19 vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer (Editorial)
John Minna, et al.
Request article

Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time? (Editorial)
Rajshekhar Chakraborty, et al.
Request article

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update (Special Article)
ASCO Guidelines, et al.
Request article

Published June 24, 2022, 4:00 PM ET:

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (Original Report)
Atsuya Takeda, et al.
Request article

Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey (Original Report)
Avram Denburg, et al.
Request article

Development of a Curriculum for the Implementation of Stereotactic Radiation Therapy Programs in Middle-Income Countries (Original Report)
Lesley Buckley, et al.
Request article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.